Vaccine Innovators Convene to Discuss New Technologies
News Mar 18, 2013
Keynote Speaker Dr. Robin Robinson, Deputy Assistant Secretary and Director Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, will lead off the three-day conference with a presentation titled “Flexible Manufacturing & Synthetic Biology Converge Towards New Defense against Threats.”
Leading scientists, business leaders and regulatory agency representatives from around the world are gathered for the scientific conference to exchange information on bringing life-saving vaccines and antibodies to market more quickly through innovative manufacturing processes. At the conference, world-leading scientists will share how these advances significantly impact responsiveness to life-threatening infectious disease epidemics and bioterrorism threats.
The event is hosted by plant-based vaccine production pioneer, Fraunhofer USA Center for Molecular Biotechnology (CMB), located at the Delaware Technology Park in Newark, Delaware, and is conducted in cooperation with the International Association for Biological Standardization (IABS), headquartered in Geneva, Switzerland.
New Advances in Vaccine Production Proven Safe, Efficient and Effective
With the growing global demand for vaccines and other biologics, development of new, alternative production technologies is critical. The latest advancements in protein production include the use of stem cell, insect cell and plant systems.
“Through the conference,” Executive Director, Fraunhofer USA Center for Molecular Biotechnology and member of the conference organizing committee Dr. Yusibov said, “we hope to exchange information about the progress made by these new technologies in the past several years and spur collaboration for additional discoveries among representatives from academic research and the biotechnology and pharmaceutical industries.”
With a focus on getting to market, topics to be discussed during the three-day conference include progress through clinical trials, technology transfer, and regulatory considerations for new technologies.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS VaccineNews
The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018